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Abstract
The obligate intracellular pathogen Chlamydia trachomatis is the most common cause of bacterial sexually transmitted
diseases in the United States. In women C. trachomatis can establish persistent genital infections that lead to pelvic
inflammatory disease and sterility. In contrast to natural infections in humans, experimentally induced infections with C.
trachomatis in mice are rapidly cleared. The cytokine interferon-c (IFNc) plays a critical role in the clearance of C. trachomatis
infections in mice. Because IFNc induces an antimicrobial defense system in mice but not in humans that is composed of a
large family of Immunity Related GTPases (IRGs), we questioned whether mice deficient in IRG immunity would develop
persistent infections with C. trachomatis as observed in human patients. We found that IRG-deficient Irgm1/m3
(-/-) mice
transiently develop high bacterial burden post intrauterine infection, but subsequently clear the infection more efficiently
than wildtype mice. We show that the delayed but highly effective clearance of intrauterine C. trachomatis infections in
Irgm1/m3
(-/-) mice is dependent on an exacerbated CD4
+ T cell response. These findings indicate that the absence of the
predominant murine innate effector mechanism restricting C. trachomatis growth inside epithelial cells results in a
compensatory adaptive immune response, which is at least in part driven by CD4
+ T cells and prevents the establishment of
a persistent infection in mice.
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Introduction
Chlamydia trachomatis is an obligate intracellular bacterial pathogen
that causes frequent infections in humans and significant morbidity
throughout the world [1]. Ocular infection with C. trachomatis is the
leading cause of preventable blindness worldwide and genital
infection with C. trachomatis is the most common bacterial sexually
transmitted infection (STI) in the United States [2,3]. The major
complications of C.trachomatisgenital tractinfections arise primarily in
women. Acute genitourinary infections with C. trachomatis remain
asymptomatic in a high proportion of infected individuals, and
therefore often go untreated. In a substantial number of infected
untreated women C. trachomatis can establish persistent infections,
which over time result in pelvic inflammatory disease and tubal
scarring and can ultimately cause infertility [4,5].
C. trachomatis is a highly specialized, human-adapted pathogen
with a narrow host range. Like many other pathogens with a very
restricted host range, C. trachomatis has evolved to cause persistent
infections in its preferred host enabling C. trachomatis to establish
reservoirs for new infections and assure its survival as a pathogen
within the human population [6]. Generally speaking, if a highly
specialized pathogen enters a non-typical or ‘‘accidental’’ host, the
non-typical host will either succumb to the infection and die or,
more commonly, will rapidly clear the infection [7]. However, it is
extremely rare for chronic infection to develop in a non-typical,
immune-competent host. This basic principle holds true for
experimental infections of laboratory mice with C. trachomatis.I n
contrast to human infections, C. trachomatis is rapidly cleared from
mice when the organisms are instilled in the vagina or directly into
the uterus [8,9]. If it were possible to model elements of human C.
trachomatis pathogenesis in mice – with a mouse model of chronic
human infection - it would accelerate the study of this disease and
therapies to combat it. A first step toward this goal is to understand
the underlying mechanisms that promote persistent C. trachomatis
infections in the human host and prevent the establishment of
chronic C. trachomatis infections in the murine host.
A milestone in dissecting the basis for host tropisms of C.
trachomatis was the discovery that IFNc-induced cell-autonomous
resistance in epithelial and other non-hematopoietic cell types like
fibroblasts fundamentally differs between mice and humans. In
human epithelial cells, IFNc exerts its antimicrobial effect on C.
trachomatis predominantly through the induction of indole-2,
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tryptophan stores, thus starving C. trachomatis, a natural auxotroph
for tryptophan, of this essential nutrient [10,11]. In contrast to
human cells, most IFNc-activated murine epithelial cells express
insufficient amounts of IDO to restrict bacterial growth, with the
notable exception of alveolar epithelial cells [10,12,13,14].
Accordingly, IDO is not required for the clearance of vaginal C.
trachomatis infections in mice [10,15]. Instead, mice restrict
Chlamydia species through a cell-autonomous resistance system
that is executed by members of a large family of IFNc-inducible
GTPases called Immunity Related GTPases or IRGs [15,16,
17,18,19,20]. Remarkably, the divergent IFNc responses of these
two host species, mice and humans, are reflected in the counter-
immune mechanisms that exist in two closely related Chlamydia
species with distinct host tropism. Whereas genital strains of the
human pathogen C. trachomatis can utilize exogenous indole to
produce tryptophan to overcome IDO-mediated growth restric-
tion, the rodent-adapted species Chlamydia muridarum has evolved a
mechanism to evade IRG-driven immune responses [19,21].
Given that the human pathogen C. trachomatis is highly susceptible
to an IRG-driven immune response that is absent in its typical
host, humans, but present in epithelial cell and fibroblasts of its
non-typical host, mice, we investigated in this study whether the
removal of the IRG resistance system would render mice
permissive for persistent C. trachomatis genital infections.
Here, we report that mice deficient for the expression of two
pivotal IRG regulatory proteins, Irgm1 (also called Lrg-47) and
Irgm3 (also called Igtp), initially develop high bacterial burden
after genital infection compared to wildtype mice. However, in
spite of the initial delay in immune clearance, Irgm1/m3
(-/-) mice
are ultimately able to resolve a C. trachomatis infection as rapidly as
wildtype mice. An exacerbated CD4
+ T cell response is essential
for the efficient clearance of genital C. trachomatis infections in
Irgm1/m3
(-/-) mice and the prevention of persistence. Our data
show that the absence of early innate immune defenses and the
resulting unrestricted expansion of C. trachomatis trigger an
amplified T cell response that results in sterilizing immunity.
Results
Deletion of Irgm3 relieves the expansion defect observed
in Irgm1
-/- CD4
+ T cells
We previously reported that Irgm1 and its paralog Irgm3 are
required for resistance to C. trachomatis in an in vivo systemic
infection model [19]. It is well established that IRG genes like
Irgm1 and Irgm3 mediate a cell-autonomous antimicrobial response
that directly targets vacuolar pathogens like C. trachomatis
[22,23,24]. More recently it has been shown that at least one
IRG family member, Irgm1, is also required for the proper
expansion of CD4
+ T cells [25]. To determine if Irgm1 and Irgm3
deficient mice were more susceptible to C. trachomatis infections due
to an intrinsic T cell deficiency, we first tested whether expression
of Irgm1 and/or Irgm3 in T cells was required for the activation
and expansion of CD4
+ T cells during an intrauterine infection
with C. trachomatis. Towards this goal we crossed the C. trachomatis-
specific, MHC class II restricted T cell receptor transgene NR1
onto the Irgm1
-/-, Irgm3
-/- and Irgm1/m3
(-/-) genetic backgrounds.
From these mice we derived naı ¨ve T cells and transferred these T
cells into recipient wildtype mice. Although transfer of an antigen
experienced or pre-activated population of NR1 cells can
accelerate bacterial clearance, the naı ¨ve activation state and the
low number of C. trachomatis-specific T cells transferred in these
experiments did not result in accelerated immune clearance, as
shown previously [26]. Therefore, the transfer of a relatively small
number of IRG-deficient NR1 cells into a wildtype host allowed us
to monitor pathogen specific immunity without altering the
normal course of the immune response [26,27]. One day after
NR1 cell transfer, we directly instilled C. trachomatis into the uterus
of these mice by a transcervical infection method. Six days post-
infection we monitored the activation and expansion of the
transferred NR1 cells in the uterus and the draining lymph nodes
of the genital tract. The transferred NR1 cells expressed an allele
of the congenic surface marker CD90 that was distinct from the
allele expressed by T cells derived from the recipient mice allowing
us to specifically detect transferred T cells. We observed that the
IRG genotype of the NR1 cells had no apparent impact on the
expression of surface activation marker CD62L and CD25
(Fig. 1A) or on the expression of the markers CD127, CD69
and CD44 (data not shown). Similarly, transferred NR1 cells of
distinct IRG genotypes were indistinguishable in regards to the
proportion of cells expressing the cytokines IFNc, TNFa and IL-2
(data not shown). However, Irgm1
-/- NR1 cells accumulated to
significantly lower numbers in the uterus than wildtype NR1 cells
did (Fig. 1B), and showed a trend towards lower cell numbers in
the draining lymph nodes of the genital tract (Fig. 1B). These data
are consistent with the previous observation that Irgm1-deficient
CD4
+ T cells fail to expand following an infection in mice [25].
Remarkably, we also found that the expansion defect of Irgm1
-/-
CD4
+ cells was reversed by the concomitant removal of Irgm3
(Fig. 1B), suggesting that Irgm1/m3
(-/-) T cells could be fully
immune-competent. To directly determine whether Irgm1/m3
(-/-)
NR1 cells could convey protection to an intrauterine infection with
C. trachomatis, we transferred Th1 skewed wildtype and Irgm1/
m3
(-/-) NR1 cells into Ifng
-/- mice and subsequently instilled C.
trachomatis directly into the uterus of these mice. In these
experiments the early clearance of the infection is solely dependent
on IFNc secreted by the transferred NR1 cells, since the recipient
mice are deficient for IFNc production [26]. We found that NR1
cells doubly deficient in Irgm1 and Irgm3 conveyed protection
against intrauterine C. trachomatis infection with an efficiency
similar to wildtype NR1 cells (Fig. 2). In sum, these data indicated
that the removal of Irgm3 salvaged the T cell intrinsic defect of
Irgm1
-/- cells and that Irgm1/3
(-/-) CD4
+ T cells were fully
functional.
The inability of Irgm1
-/- NR1 cells to expand to similar numbers
as wildtype NR1 cells at the site of the infection could be explained
by the propensity of Irgm1-deficient mature CD4
+ T cells to
prematurely die when activated for proliferation [25]. Considering
Author Summary
Chlamydia trachomatis is the most common cause of
bacterial sexually transmitted disease and can lead to
pelvic inflammatory disease, ectopic pregnancy, infertility,
and other complications in women. These serious compli-
cations have been difficult to study experimentally in
laboratory animals because C. trachomatis only causes
these complications in humans. Previous work in our
laboratory has identified two mouse genes responsible for
resistance to C. trachomatis. Here we consider whether
mice lacking the two resistance genes might succumb to
the same complications of infection observed in humans.
Although initial infection of the mice lacking the two
resistance genes is greater in magnitude compared to
normal mice, eventually the mice resist serious infection.
We found that one component of the mouse immune
system, the T cells, expands more robustly to compensate
for the lack of the resistance genes.
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expansion defect of Irgm1
-/- NR1 cells, we hypothesized that the
simultaneous deletion of Irgm3 might serve to reverse the
premature cell death phenotype of Irgm1
-/- CD4
+ T cells. To test
this idea, we labeled wildtype, Irgm1
-/-, Irgm3
-/- and Irgm1/m3
(-/-)
CD4
+ T cells with CFSE and then activated them for proliferation
using plate-bound anti-CD3 and anti-CD28 antibodies for 72
hours. As reported previously [25], we observed increased total cell
death of Irgm1
-/- T cells compared to wildtype cells using
propidium iodide incorporation as a measure for cell death
(Fig. 3). The increase in cell death in Irgm1
-/- T cells compared to
wildtype cells was most pronounced in the population of CFSE
high
cells that had only undergone a few rounds of cell division.
However, Irgm1/m3
(-/-) T cells showed a significant decrease in cell
death compared Irgm1
-/- T cells and the total percentage of dead
Irgm3
-/- and Irgm1/m3
(-/-) T cells was similar to wildtype T cells
(Fig. 3). Taken together, these data showed that the deletion of
Irgm3 reverses the T cell expansion and cell survival defect found
in Irgm1-deficient T cells.
Irgm1/m3
(-/-) fibroblasts are deficient for IFNc-induced
cell-autonomous resistance to C. trachomatis
IFNc-activated cells lacking Irgm1 expression are impaired in
their ability to contain the intracellular growth of various
intracellular pathogens including Salmonella typhimurium, Toxoplasma
gondii and C. trachomatis [22,23,24]. Recently, it has been shown
that Irgm1-deficient cells can regain the ability to fully restrict
growth of S. typhimurium when an additional genetic lesion in Irgm3
is introduced, suggesting that Irgm1 and Irgm3 are not essential to
restrict S. typhimurium inside an infected cell [28]. In contrast, IFNc-
activated cells doubly deficient in Irgm1 and Irgm3 remain at least
as susceptible to a T. gondii infection as cells harboring single Irgm
gene deletions [28]. To determine whether Irgm1 and Irgm3 are
essential for IFNc-induced cell-autonomous resistance to C.
trachomatis, we generated Irgm1/m3
(-/-) mouse embryonic fibroblasts
(MEFs). MEFs lacking both Irgm1 and Irgm3 displayed a near
complete loss of IFNc-induced resistance to C. trachomatis growth.
Whereas only very few C. trachomatis inclusion were detectable in
IFNc-activated wildtype MEFs, the number of inclusions found in
IFNc-treated and untreated Irgm1/m3
(-/-) MEFs was similar
(Fig. 4A). To more accurately quantify C. trachomatis replication
in these MEFs, we harvested DNA from infected cells at 4 and 30
hours post-infection (hpi) and measured the amount of Chlamydia
DNA using qPCR. Neither IFNc treatment nor IRG deficiency
had any appreciable effect on C. trachomatis burden at 4 hpi,
suggesting normal bacterial attachment and entry under all
conditions. By 30 hpi IFNc activation, C. trachomatis yields were
reduced by nearly 2 logs in wildtype MEFs. In contrast, we only
observed a 2-fold reduction in IFNc-treated Irgm1/m3
(-/-) MEFs
(Fig. 4B). Because it was formally possible that C. trachomatis was
Figure 1. Concomitant deletion of Irgm3 rescues the expansion defect of Irgm1
-/- CD4
+ T cells. Wildtype B6 mice were injected with naı ¨ve,
NR1-transgene expressing T cells derived from mice with the indicated genotypes. The next day mice were challenged with 2 * 10
6 IFUs of C.
trachomatis directly instilled into the uterus. On day 6 post-infection, flow cytometry was used to analyze cells from the uterus and draining lymph
node (A). C. trachomatis-specific NR1 cells resident in the iliac lymph nodes were assessed for the expression of activation markers CD25 and CD62L.
Total CD4
+ cells are shown as gray dots, NR1 cells are shown as black dots. (B) The percentage of total live NR1 cells was calculated for uterus (left
panel) and draining lymph node (right panel). Flow cytometry data are representative of three independent experiments. Statistical analysis was
performed via Student’s t test. *, p,0.05.
doi:10.1371/journal.ppat.1001346.g001
T Cells Clear Chlamydia from IRG-Deficient Mice
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elementary bodies in IFNc-activated Irgm1/m3
(-/-) MEFs, we also
assayed the release of infectious EBs by monitoring the production
of inclusion forming units (IFUs) in these cells. Consistent with our
findings by qPCR (Fig. 4B), we found that the ability of IFNc-
activated MEFs to restrict the production of infectious C.
trachomatis progeny was severely compromised in Irgm1/m3
(-/-)
MEFs (Fig. 4C). Collectively, our results showed that Irgm1/m3
(-/-)
MEFs have lost their ability to efficiently restrict growth of C.
trachomatis upon IFNc activation.
Because these experiments were conducted in tryptophan-rich
culture media, we could not dismiss a possible role for the
tryptophan-degrading enzyme IDO in restricting C. trachomatis
growth in IFNc-activated MEFs. To test for such a function of
IDO, we first measured induction of mouse IDO1 expression
upon IFNc activation. In contrast to the approximately 1000-fold
induction of Irgm3 and Irgb10 mRNA expression, IDO1 mRNA
was only moderately induced (5-fold), and more importantly,
inhibition of C. trachomatis growth upon IFNc treatment remained
unchanged in the presence or absence of tryptophan in the culture
media (Fig. S1A and B). Because ectopic expression of IDO
resulted in significant restriction of C. trachomatis growth in MEFs
(Fig. S1C), we conclude that endogenous IDO expression levels
are too low in IFNc-stimulated MEFs to restrict C. trachomatis
growth.
Initially delayed but subsequently accelerated clearance
of intrauterine C. trachomatis infections in Irgm1/m3
(-/-)
mice
Since MEFs isolated from Irgm1/3
-/- mice failed to constrain C.
trachomatis growth in the presence of IFNc, we expected that these
mice would also be unable to control C. trachomatis genital
infections. To test this idea, we infected wild type, Ifngr1
-/-, and
Irgm1/m3
(-/-) mice transcervically with C. trachomatis and measured
the bacterial burden in the genital tract over 45 days. As expected,
mice lacking the gene encoding the IFNc receptor (Ifngr1
-/-)
showed greater bacterial burden than wildtype mice over the
entire time course (Fig. 5). Initially Irgm1/m3
(-/-) mice also
developed high bacterial burden similar to the burden observed
in Ifngr1
-/- mice, yet by day 15 post-infection the number of
organisms present in Irgm1/m3
(-/-) mice was reduced to levels
similar to the ones found in wildtype mice (Fig.5). By day 45 post-
infection, C. trachomatis was still detectable in Ifngr1
-/- mice but
undetectable in wildtype and Irgm1/m3
(-/-) mice. These data show
that although Irgm1/m3
(-/-) mice were initially defective in clearing
C. trachomatis infections, they ultimately were able to control the
infection. Therefore, we conclude that Irgm1/m3
(-/-) mice do not
exhibit an infection of extended duration as had been observed
with the Ifngr1
-/- mice.
An exacerbated CD4
+ T cell response mediates the
clearance of intrauterine C. trachomatis infection in
Irgm1/m3
(-/-) mice
We then began to investigate how Irgm1/m3
(-/-) mice were able
to clear C. trachomatis infections despite the initially high bacterial
burden observed at day 5 and earlier. One possible explanation
was that the increased antigen burden in the Irgm1/m3
(-/-) mice
stimulates the expansion and activation of C. trachomatis-specific
effector T cells. To test the idea that host Irgm1/m3-deficiency
could impact the development of wildtype T cells, we transferred
naı ¨ve, CFSE-labeled, wildtype C. trachomatis-specific NR1 cells into
wildtype, Ifngr1
-/- or Irgm1/m3
(-/-) host mice. Although we had
already shown that Irgm1/m3
(-/-) T cells appear to be indistin-
guishable from wildtype T cells (Fig. 1 and 2), we opted to use
wildtype NR1 cells in these experiments in order to exclude any
cell-autonomous effects on T cells that could be caused by the
presence of the Ifngr1
-/- or the Irgm1/m3
(-/-) alleles. One day after
the transfer of wildtype NR1 cells into mice of the indicated
genotypes, mice were infected with C. trachomatis in the uterus. We
found that C. trachomatis infection stimulated robust proliferation of
transferred NR1 cells regardless of the genotype of the recipient
mice (Fig. 6A, top panel). Though the genotype of the recipient
mouse had no discernable impact on NR1 cell proliferation based
on CSFE dye dilution, we did observe a significant increase in the
total number of NR1 cells in the iliac lymph node (Fig. 6A and 6B)
and the uterus (Fig. 6C) of Irgm1/m3
(-/-) mice on day 6 post-
infection compared to Ifngr1
-/- and wildtype mice. The greater
expansion of NR1 cells in Irgm1/m3
(-/-) mice corresponded to an
increase in the population of NR1 cells expressing the IL-2 high
affinity receptor CD25 on NR1 cells resident in C. trachomatis-
infected Irgm1/m3
(-/-) mice compared to infected Ifngr1
-/- and
wildtype mice (Fig. 6A). Additionally, a significantly larger
proportion of NR1 cells expressed IFNc, the hallmark cytokine
of Th1 activation, and the proinflammatory cytokine TNFa in
combination with IFNc, when transferred into Irgm1/m3
(-/-)
recipient mice compared to Ifngr1
-/- and wildtype recipient mice
(Fig. 6D). As expected for conventional Th1 cells, we did not
detect significant IL-17 expression in NR1 cells transferred into
either wildtype or Irgm1/m3
(-/-) mice on day 6 post-infection (data
not shown).
These results suggested that enhanced expansion of C.
trachomatis-specific T cells and a boost in their activation status
may compensate for the loss of innate immune restriction due to
the Irgm1 and Irgm3 mutations. To prove that a compensatory
amplification of the T cell response was responsible for clearance
of C. trachomatis from the genital tract, we subjected groups of
Irgm1/m3
(-/-) and wildtype mice to multiple treatments with either
Figures 2. C. trachomatis-specific CD4
+ T cells lacking Irgm1 and
Irgm3 convey protection to an intrauterine infection with C.
trachomatis. Th1-skewed wildtype NR1 cells or Irgm1/m3
(-/-) NR1 cells
were adoptively transferred into mice deficient for IFNc production
(Ifng
-/- mice). The following day these mice were transcervically infected
with 2 * 10
6 IFUs of C. trachomatis. Three days post-infection, uteri were
taken from sacrificed mice and bacterial yield was quantified using
qPCR. Data are representative of two independent experiments.
Statistical significance relative to the no transfer group is indicated as
*, p,0.05. n.s. = not significant.
doi:10.1371/journal.ppat.1001346.g002
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bacterial burden in the uterus at 15 days post-infection. As
expected, depleting CD4
+ T cells resulted in greater bacterial
burden in both wildtype as well as Irgm1/m3
(-/-) mice relative to
control mice of the same genotype, confirming that the adaptive
immune response contributes to immune clearance at later times
in the course of the infection (Fig. 7). Depletion of CD4
+ T cells,
however, had a greater effect on bacterial burden in Irgm1/m3
(-/-)
Figure 3. Concomitant deletion of Irgm3 rescues the cell death phenotype of Irgm1
-/- CD4
+ T cells. Flow cytometry of CFSE-labeled
wildtype, Irgm1
-/-, Irgm3
-/- and Irgm1/m3
(-/-) CD4
+ T cells that had been activated with anti-CD3 and anti-CD28 antibodies in the presence of IL-2 for 72
hours and were subsequently stained for dead cells with propidium iodide. Percentages and standard deviations are given for each quadrant (upper
panel). The total percentage of propidium iodide positive cells is shown for each genotype. The filled area of the bar indicates the fraction of CFSE
low
cells and the open area marks the fraction of CFSE
high cells (lower panel). Data are representative of three independent experiments. Statistical
significance for the percentages of total cell death is indicated as *, p,0.05.
doi:10.1371/journal.ppat.1001346.g003
T Cells Clear Chlamydia from IRG-Deficient Mice
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uterus by two logs instead of one log. These data confirmed that
Irgm1/m3
(-/-) mice compared to wildtype mice developed an
exacerbated T cell response that was instrumental in the rapid
clearance of genital infection with C. trachomatis.
Neutrophil infiltration to the uterus is enhanced in C.
trachomatis infected Irgm1/m3
(-/-) mice compared to
wildtype mice
We then began to investigate the mechanism by which an
exacerbated CD4
+ T cell response clears C. trachomatis infections in
mice lacking cell-autonomous IRG resistance in epithelial cells.
Because of the recent demonstration that Chlamydia-specific T cells
can control Chlamydia replication inside epithelial cells by a Nos2-
dependent mechanism [29], we tested whether Nos2 was
responsible for the elimination of C. trachomatis in Irgm1/m3
(-/-)
mice. To test this hypothesis, we generated Irgm1/m3
(-/-)Nos2
(-/-)
triple knockout mice. Although C. trachomatis-infected Irgm1/m3
(-/-)
Nos2
-/- mice trended towards higher bacterial burden compared to
Irgm1/m3
(-/-) or wildtype mice, this effect was not statistically
significant in our experiments (Fig. S2).
While exploring alternative CD4-dependent immune mecha-
nisms targeting C. trachomatis in Irgm1/m3
(-/-) mice, we identified an
increase in the uterine population of cells expressing the neutrophil
surface marker GR1 relative to wildtype mice at day15 post-
infection. An increase in the number of GR1
+ cells was also
observed in the iliac lymph nodes but not in the spleen of Irgm1/
m3
(-/-) mice (Fig. 8A). Similar to the depletion of CD4
+ T cells, the
depletion of the GR1
+ cell population or the simultaneous
depletion of CD4
+ and GR1
+ cells in Irgm1/m3
(-/-) mice resulted
in a dramatic increase in bacterial burden (Fig. 8B), suggesting an
important role for neutrophils in the elimination of C. trachomatis in
Irgm1/m3
(-/-) mice.
Lastly, we explored the question as to why Irgm1/m3
(-/-) mice
cleared C. trachomatis infections more efficiently than Ifngr1
-/- mice
did (Fig. 5). Both Irgm1/m3
(-/-) and Ifngr1
-/- mice lack IRG-
mediated cell-autonomous resistance, yet differ in the number and
activation status of their Chlamydia-specific T cell population
(Fig. 6). To determine whether T cells in conjunction with
neutrophils are responsible for the relatively more efficient
elimination of C. trachomatis in Irgm1/m3
(-/-) mice compared to
Ifngr1
-/- mice, we treated Irgm1/m3
(-/-), Ifngr1
-/- and wildtype mice
with anti-CD4 and anti-GR1 depleting antibodies, and deter-
mined bacterial burden at 15 days post infection. As expected,
bacterial burden was dramatically elevated in all CD4/GR1-
depeleted animals regardless of their genetic background.
However, the most dramatic effect on bacterial burden was
observed in Irgm1/m3
(-/-) mice (Fig. S3) elevating the bacterial yield
to the same levels observed in similarly treated Ifngr1
-/- mice.
These results suggest that IFNc directs T cell- and neutrophil-
dependent clearance of C. trachomatis infections.
Discussion
Genital infections with C. trachomatis are among the most
common STI worldwide and constitute the most frequent bacterial
STI in the United States. Asymptomatic and consequently
unrecognized and untreated C. trachomatis infections can ascend
from the cervix to the fallopian tube and establish persistence
resulting in irreversible tissue damage and infertility [30,31]. In
contrast to humans, mice clear genitourinary infection with C.
trachomatis rapidly and members of the IRG gene family play an
important role in conveying resistance to C. trachomatis infections in
the mouse. Whereas the importance for IRG proteins in resistance
to C. trachomatis infections in mice is undisputed, the function of the
constitutively expressed human ortholog IRGM in the pathogen-
esis of human C. trachomatis infections is less clear. Although IRGM
induces antimicrobial xenophagy in human cells [32,33,34,35],
most human cells restrict growth of C. trachomatis by an IDO-
dependent and apparently IRGM-independent mechanism
([10,11,15] and Fig. S1B). Although IRGM may still prove to be
important in providing resistance to C. trachomatis infections in
some cell types or tissues, IRGM is less likely to play a prominent
role in the pathogenesis of human C. trachomatis infections. For
these reasons, we sought to determine whether mice deficient in
Figure 4. Cells doubly deficient for Irgm1 and Irgm3 exert
minimal IFNc-induced cell-autonomous resistance to C. tracho-
matis. IFNc-stimulated and unstimulated MEFs derived from wildtype
B6 or Irgm1/m3
(-/-) mice were infected with C. trachomatis at an MOI of
2. (A) Cell nuclei were stained with DAPI and C. trachomatis inclusions
were labeled using an anti-Hsp70 antibody (B) Bacterial growth was
quantified using qPCR at 4 and 30 hpi and (C) using an inclusion-
forming unit (IFU) assay at 48 hpi. Data is representative of at least two
independent experiments.
doi:10.1371/journal.ppat.1001346.g004
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humans in that regard - would develop persistent C. trachomatis
infections.
We have previously shown that two members of the IRG gene
family, Irgm1 and Irgm3, mediate resistance to C. trachomatis in an in
vivo model of systemic infection [19]. Because the gene Irgm1 not
only conveys cell-autonomous resistance to vacuolar pathogens
inside an infected host cell but is also required to prevent the
premature cell death of activated, proliferating CD4
+ T cells, we
first tested the hypothesis that the inability of IRG-deficient mice
to efficiently restrict C. trachomatis infections could partly be due to
a diminished CD4
+ T cell response. We found that Irgm1
-/- CD4
+
T cells specific for a C. trachomatis epitope failed to efficiently
expand in the uterus of genitally infected animals and prematurely
died when activated for proliferation ex vivo. These results are
consistent with the previously described expansion defect of
Irgm1
-/- CD4
+ T cells [25]. However, we also found that the
simultaneous removal of Irgm3 in Irgm1/m3
(-/-) CD4
+ T cells
‘rescued’ the phenotype of Irgm1
-/- CD4
+ T cells. Two alternative
models may account for these observations: the first model is based
on the published finding that IFNc-induced IRG proteins form
large protein aggregates in the absence of Irgm1 expression
[36,37]. These protein aggregates are not found in IFNc-activated
wildtype cells and are likely to have cytotoxic properties. The
concomitant removal of Irgm3 has been shown to reduce the levels
of IRG protein aggregates inside a cell, possibly below a threshold
level of toxicity [28]. Because T cells have a relatively small
cytoplasmic volume compared to most differentiated cells, they
may be particularly susceptible to the cytotoxic effects of IRG
protein aggregates. According to the ‘‘aggregate model’’ recently
proposed by Hunn and Howard [38], the expansion defect of
Irgm1
-/- CD4
+ T cells could be due to the cytotoxicity of IRG
protein aggregates that form when the finely balanced network of
IRG protein interactions is artificially disrupted by the Irgm1 gene
deletion. In a second, alternative, model IFNc-induced IRG
mediated cell death in T cells is a regulated biological process that
plays an important role in fine-tuning T cell homeostasis. Our
observations can be reconciled with a model in which Irgm3
protein acts as an inducer of cell death whereas Irgm1promotes
cell survival, functioning as an Irgm3 antagonist. According to this
model, regulated changes in the expression of Irgm1 relative to
Irgm3 or post-translational modifications of either Irgm protein
could shift the balance towards either T cell survival or T cell
death in wildtype T cells. Removal of the pro-survival factor Irgm1
in Irgm1
-/- T cells would result in uncontrolled cell death due to the
unrestricted action of Irgm3. Further removal of the pro-death
factor Irgm3 in Irgm1/3 T cells would restore cell survival. In
support of the latter model, we found that anti-CD3 stimulated
Irgm3
-/- CD4
+ T cells showed improved cell viability compared to
wildtype T cells at least during the first few rounds of anti-CD3
stimulated cell division (Fig. 2), suggesting that Irgm3 may indeed
function as a pro-cell death molecule. Additionally, we observed
that Irgm3
-/- mice (but not Irgm1
-/- or wildtype mice) expressing
the NR1 transgene relatively frequently developed lymphoma with
advanced age (JC and MNS, unpublished data), indicating a
potential role for Irgm3 as a tumor suppressor gene. Beyond the
uncertainty of the biological functional importance of IRG
proteins in murine T cells, the additional unanswered question
remains as to whether IRGM, the single human IRG ortholog
constitutively and ubiquitously expressed in human cells, plays any
role in regulating T cell homeostasis.
Because Irgm1/3 double deficiency does not intrinsically affect
T cell expansion or function, we were able to investigate whether
the absence of IRG-mediated resistance in epithelial cells in an
otherwise immune-competent host would impact the course and
duration of a genital C. trachomatis infection. We found that Irgm1/
m3
(-/-) mice initially failed to effectively clear C. trachomatis during
the early course of an infection. This observation can be
explained with a nearly complete defect in IFNc-induced cell-
autonomous resistance in cells doubly deficient in Irgm1 and Irgm3
(Fig. 3). At later time points, however, Irgm1/m3
(-/-) mice cleared
genital C. trachomatis infections rapidly due to an exacerbated
Figure 5. Irgm1/m3
(-/-) mice show delayed but efficient clearance of genital C. trachomatis infections. B6 wildtype mice and the coisogenic
knockout strains B6.Ifngr1
-/-, and B6.Irgm1/m3
(-/-) were transcervically infected with 2 * 10
6 IFUs of C. trachomatis. At the indicated days post-infection
3 to 4 mice of each genotype were sacrificed and bacterial burden in the uteri was quantified by qPCR. Data were combined from two independent
experiments. Statistical analysis of box-and-whisker plots was done via Student’s t test and significant difference relative to wildtype mice and
between Ifngr1
-/-, and Irgm1/m3
(-/-) are indicated by *, p,0.05. The limit of detection was approximately 10
24 pg 16S DNA/mg host DNA.
doi:10.1371/journal.ppat.1001346.g005
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+ T cell response. The observation that
Irgm1/m3
(-/-) mice developed a more pronounced T cell response
towards C. trachomatis than Ifngr1
-/- mice did, can be explained by
the important role IFNc plays in stimulating the adaptive
immune response, for example, through improved antigen
presentation allowing for direct cytolysis by degranulating CD4
T cells [29] and/or enhanced neutrophil recruitment and survival
[39,40,41,42]. It has also been reported that IFNc acts as a
positive regulator of CD25 expression on CD4+ T cells in a
mouse model of myocarditis, though it is unclear whether IFNc
directly or indirectly controls CD25 expression in CD4+ T cells
[43]. The boost in CD25 surface expression on wildtype NR1
cells resident in C. trachomatis-infected Irgm1/m3
(-/-) mice com-
pared to C. trachomatis-infected Ifngr1
-/- mice may therefore be the
Figure 6. The absence of Irgm1/3-dependent immunity results in an exacerbated CD4
+ T cell response. CFSE-labeled, wildtype NR1cells
were adoptively transferred into recipient mice of the indicated genotypes. The mice were subsequently transcervically infected with 2 * 10
6 IFUs of
C. trachomatis. On day 6 post-infection, flow cytometry was used to analyze cells from the uterus and draining lymph node. Representative data of
four independent experiments are shown. (A) A total of 10
6 lymphocytes were collected in each sample and the absolute number of CD4
+ CD90.1
+
NR1 cells was analyzed for CFSE dye dilution (upper panel) and expression of the surface proteins CD25 and CD62L (lower panel). All cells derived
from the draining lymph nodes were used for the analysis. The number of C. trachomatis-specific NR1 cells is shown as the percentage of total
number of cells in the iliac lymph node (B) and the uterus (C). (D) NR1 cells harvested from the iliac lymph node were also restimulated for 5 h with
PMA-ionomycin and assessed for intracellular cytokine staining. Statistical significance relative to wildtype recipient mice is shown. *, p,0.05;
**, p,0.01; and ***, p,0.005.
doi:10.1371/journal.ppat.1001346.g006
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activation of antigen presenting cells. In addition to an increase
in CD25 expression on NR1 cells, we also observed greater
accumulation of NR1 cells in C. trachomatis infected Irgm1/m3
(-/-)
mice compared to C. trachomatis infected wildtype or Ifngr1
-/- mice.
It seems likely that these two phenotypes are linked: the surface
protein CD25 is identical to the alpha chain of the high-affinity,
trimeric IL-2 receptor and expression of CD25 has been shown to
be upregulated on activated conventional T cells [44,45].
Although signaling through the IL-2 receptor is not essential
for T cell effector function in vivo, IL-2 is known to promote T cell
survival and expansion [46,47,48,49]. The increase in CD25
expression in NR1 cells and the resulting boost in IL-2 mediated
cell survival may therefore be the underlying cause for the greater
expansion of NR1 cells that we observed in C. trachomatis infected
Irgm1/m3
(-/-) mice. Collectively, these data indicate that the
virtual absence of cell-autonomous host resistance during the
early course of a C. trachomatis infection triggers a compensatory
adaptive immune response in an otherwise fully immune-
competent host and ultimately prevents the establishment of a
sustained genital infection with C. trachomatis in mice.
These results prompt the question of how C. trachomatis can
prevent clearance by the adaptive immune response in its natural
host, humans, which lack a robust IRG-dependent immune
response that targets C. trachomatis directly. We propose that the
answer to this question lies in the adaption of C. trachomatis to a
different cell-autonomous IFNc response – one found in humans
Figure 7. Dependency on the CD4
+ T cell response for clearing
intrauterine C. trachomatis infections is increased in Irgm1/m3
(-/-)
mice. Groups of wildtype B6 and Irgm1/m3
(-/-) mice were treated with
either ant-CD4 depleting or control antibodies as described in Materials
and Methods. At 15 days post-infection mice were sacrificed and
bacterial burden in the uteri was determined by qPCR. The fold increase
in bacterial burden following treatment with anti-CD4 antibody
compared to control antibody-treated mice is shown. The increase in
burden in anti-CD4-treated Irgm1/m3
(-/-) mice was significantly higher
than in wildtype mice (*, p,0.05). Data are representative of three
independent experiments.
doi:10.1371/journal.ppat.1001346.g007
Figure 8. A neutrophil surge into the uterus of C. trachomatis-
infected Irgm1/m3
(-/-) mice plays a role in immune clearance. (A)
Wildtype or Irgm1/m3
(-/-) mice were transcervically infected with C.
trachomatis. Fifteen days later, the uterus (UT), iliac lymphnodes (LN),
and spleens (SP) of these mice were assessed for lymphocyte
populations via FACS analysis. Macrophage populations were gated
via CD11b
+GR1
low, while neutrophil populations exhibited a
CD11b
+GR1
high phenotype. Average percent of total is represented
on the right of the gated population +/- standard deviation. Neutrophil
populations in uteri and lymph nodes were statistically different
between wildtype and Irgm1/m3
(-/-) mice (p,0.05). (B) Irgm1/m3
(-/-)
mice were treated with depleting antibodies as described in Materials
and Methods and 15 days post-infection bacterial burden in the spleen
was measured by qPCR. Significant increases in bacterial burden in
antibody-treated Irgm1/m3
(-/-) mice compared to mice treated with an
isotype control antibody are indicated (*, p,0.05). The data are
representative of two independent experiments.
doi:10.1371/journal.ppat.1001346.g008
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epithelial cells in mice [50]. A wealth of in vitro experimental data
shows that IFNc activation of human epithelial cells results in the
expression of IDO, which leads to the depletion of intracellular
tryptophan stores [10,51,52,53,54]. In response to tryptophan
starvation, C. trachomatis transforms from an active, replicating,
state into a quiescent form [55]. Replication of these organisms
stops, yet they endure in a quiescent form until immune response
wanes and tryptophan becomes available again [4,5,55,56,57].
The IDO-induced, non-replicating quiescent organisms are less
likely to trigger a strong adaptive immune response due to reduced
antigenic burden. Additionally, the quiescent bacterium may be
more resistant to immune effector mechanisms than its replicating
form. We therefore propose that in order to avoid clearance by the
adaptive immune response, C. trachomatis has evolved to co-opt the
IDO-driven cell-autonomous immune response as an inducer of
bacterial quiescence. Accordingly, a humanized mouse model for
chronic C. trachomatis infections would require both the removal of
the murine IRG response and the recreation of IDO-mediated
cell-autonomous immunity in urogenital epithelial cells.
Materials and Methods
Ethics statement
All experiments were approved by the Institutional Animal Care
and Use Committee of Harvard Medical School. Harvard
maintains an animal care and use program certified by The
Association for the Assessment and Accreditation of Laboratory
Animal Care (AAALAC) and all procedures are conducted in
accordance with guidelines established by the American Veteri-
nary Medical Association.
Mice
All mice were maintained and bred under specific pathogen-free
conditions. Control C57BL/6J (wildtype) B6.Ifngr1
-/- and B6.Ifng
-/-
mice were obtained from The Jackson Laboratory. The targeted
gene deletions of Irgm1 and Irgm3, mice doubly deficient for Irgm1
and Irgm3 and NR1 mice expressing a TCR transgene specific for
the C. trachomatis antigen Cta1 have been described previously
[27,28,58,59]. The NR1 T cell receptor transgene was crossed
onto the Irgm1
-/-, Irgm3
-/- and Irgm1/m3
(-/-) genetic backgrounds.
C. trachomatis strains and measurement of inclusion
forming units and bacterial genomes
C. trachomatis serovar L2 434/Bu were propagated in McCoy
cells and purified as described [17]. Cells were routinely cultured
in high glucose DMEM (Gibco) supplemented with 10% fetal calf
serum. For those experiments in which we monitored the
antimicrobial effects of IDO-mediated tryptophan depletion, cells
were transferred into DMEM F-12 culture medium lacking
tryptophan (US Biological) supplemented with 3% fetal calf
serum. Limiting the amount of calf serum was necessary to reduce
the amount of serum-derived tryptophan to levels at which IFNc-
activated HeLa cells maximally restricted growth of C. trachomatis.
Where indicated media was supplemented with tryptophan at a
final concentration of 0.05 mg/ml. To quantify the bacterial load
in Chlamydia-infected cells and in the uteri of infected animals, a
previously described quantitative PCR assay was applied [17].
Briefly, total nucleic acid from infected cells or spleen homoge-
nates was prepared using the QIAamp DNA mini kit from
Qiagen. Chlamydia 16S DNA and mouse GAPDH DNA content of
individual samples was then quantified by qPCR on an ABI 7000
sequence detection system using primer pairs and dual-labeled
probes. Standard curves were generated from known amounts of
Chlamydia and mouse DNA, and these curves were used to
calculate the mass of Chlamydia DNA per unit mass of mouse DNA
in the samples. Alternatively, infected cells in culture were lysed by
sonication and combined with their culture supernatants. Serial
dilutions of the lysate were applied to McCoy cell monolayers.
Inclusions were counted by immunofluorescence microscopy 30
hours post-infection.
Cell culture and C. trachomatis infections ex vivo, and
microscopy
Mouse embryonic fibroblasts were generated from the indicated
mouse strains as previously described [17]. Cells were treated with
100 U/ml recombinant mouse IFNc (Chemicon International)
over night before infection or left untreated. Cells were infected
with C. trachomatis at a multiplicity of infection (MOI) of 2 in SPG
buffer (220 mM sucrose, 12.5 mM phosphate, and 4 mM L-
glutamic acid (pH 7.5) by centrifugation at 1928 x g for 1 h at
37uC and then returned to standard medium. Chlamydia inclusions
were detected in infected cells using mouse anti-Hsc70 antibody
(Abcam), followed by anti-mouse secondary fluorescently labeled
antibody. Cell nuclei were visualized with 49,6-diamidino-3-
phenylindole (DAPI) staining and epifluorescent images were
acquired with a Nikon Eclipse TE2000-U microscope using a
Nikon Plan Apo 20x /0.75 N.A. Phase 2 objective. Images were
saved as TIFF files and imported into Adobe Illustrator for
labeling.
Transfer of C. trachomatis-specific CD4
+ T cells, anti-CD4
and anti-GR1 antibody depletion, and intrauterine
infection
Before transfer, C. trachomatis-specific CD4
+ T cells were isolated
from peripheral lymphoid tissues of mice transgenic for the NR1
TCR (Va2
+,V b8.3
+) and labeled with 5 mM carboxyfluorescein-
diacetate-succinimidyl-ester (CFSE) in serum-free medium as
described [26]. One day before an intrauterine infection with C.
trachomatis recipient CD90.2
+ mice were injected i.v. with 10
6
lymphocytes derived from NR1 transgenic animals of the
indicated genetic backgrounds and congenically marked with the
surface marker CD90.1
+. To infect the genital tract, mice were
treated with 2.5 mg of medroxyprogestrone acetate s.c. and one
week later 2*10
6 inclusion-forming units of C. trachomatis L2
were instilled into the uterus using a commercially available non-
surgical embryo transfer device (Paratechs). In order to deplete
CD4
+ T cells, mice were injected intraperitoneally with 0.5 mg
anti-CD4
+ mAb (GK 1.5) two days prior to infection and with
0.25 mg of the same antibody on days 0, 2, 5, 7, 9 and 12 post-
infection. To deplete GR1
+ cells, mice were injected with the anti-
GR1
+ depleting antibody RB6-8C5 and control mice were
injected with the isogenic rat IgG2b antibody LTF-2 (BioXCell)
following the same injection regiment.
Tissue preparation and flow cytometry
At the indicated times post-infection, lymph nodes and uteri were
collected. Uteri were digested with 1 mg/ml type XI collagenase
and 50, 000 units/ml DNase for 45 minutes at 37uC. Single-cell
suspensions were prepared for staining via mechanical disaggrega-
tion. Tissues were mechanically disaggregated and immediately
stained for activation markers or stimulated for 5 h with 50 ng/ml
PMA and 500 ng/ml ionomycin in the presence of brefeldin A to
determine intracellular cytokine staining. Cells were preincubated
with anti-FcRc (Bio X-Cell) before staining with anti-CD4 Pacific
Blue (Biolegend), anti-CD90.1 peridinin chlorophyll-a protein (BD
Bioscience), and Live/Dead Aqua (Invitrogen). For activation
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750 (Ebioscience), and anti-CD25 allophycocyanin (BD Bioscience).
For intracellular staining, the following antibodies were used: anti-
IFNc-PE or -Alexa 700; anti-IL2-PE or -allophycocyanin; and anti-
TNFa-PE or -PE-CyChrome 7 (BD Biosciences). Cells were
permeabilized with the Cytofix/Cytoperm Plus kit according to
the manufacturer’s instructions (BD Bioscience). In all samples, an
unbiased total of 10
6 lymphocytes were collected based on forward
and side scatter gating. Post-acquisition, lymphocytes were gated
based on forward and side scatter, dead cells were excluded, and
NR1
+ cells were delineated by gating on CD4
+, CD90.1
+,V a2
+,
Vb8.3
+ T cells events. Data were collected on a modified
FACSCalibur (Cytek Development) or an LSRII (BD Bioscience)
and analyzed using Flow Jo (Tree Star).
Proliferation and cell death assay
Spleens were mechanically disaggregated, red blood cells were
lysed and cell suspension was enriched for CD4
+ T cells using the
Dynal Mouse CD4
+ Negative Isolation Kit (Invitrogen) according
to the manufacturer’s instructions. Isolated cells were CFSE
labeled and 10
5 cells were plated out in wells of a 96-well flat
bottom plates coated with anti-CD3 (500 ng/ well) and anti-CD28
(50 ng/ well) antibodies. Three days later cell viability was assessed
by flow cytometry with propidium iodide staining.
T cell protection assay
CD4
+ T cells were purified from NR1 mice using a mouse
CD4
+ isolation kit (Dynal; Invitrogen) per the manufacturer’s
directions. The T cells were cultured in RPMI 1640 (Invitrogen)
supplemented with 10% FCS, L-glutamine, HEPES, 50 mM2 -
ME, 50 U/ml penicillin, and 50 mg/ml streptomycin. To
stimulate the T cells, irradiated feeder splenocytes were pulsed
with 5 mM Cta1133–152 peptide and co-cultured with the CD4
+-
enriched NR1 cells at a stimulator to T cell ratio of 4:1. To
polarize T cells towards Th1, T cells were incubated with 10 ng/
ml IL-12 (Peprotech) and 10 mg/ml anti-IL-4 (Biolegend) for 5–7
days. 10
7 Th1-skewed C. trachomatis-specific CD4
+ T cells were
transferred into mice, and 24 h later mice were infected in the
uterus as described above. Uteri were harvested 6 days after
infection. To assess the protective capacity of the skewed cells,
uteri from infected mice were homogenized, and DNA was
prepared as described above and used for qPCR.
Statistical analysis
All groups were evaluated for statistical significance through
the use of unpaired two-tailed t tests. Where it appeared nec-
essary to highlight significant differences between data points,
the level of significance is depicted as: *, p,0.05; **, p,0.01; and
***, p,0.005.
Supporting Information
Figure S1 Induction of murine IDO1 by IFNc is unable
to restrict growth C. trachomatis. (A) B6 MEFs were
stimulated with IFNc and the induction of IDO1, Irgb10 and Igtp
was determined using qPCR. (B) B6 MEFs, Irgm1/m3
(-/-) MEFs,
and HeLa cells were stimulated with 100U IFNc/ml (mouse or
human, respectively) over night and subsequently infected with C.
trachomatis in the presence or absence of tryptophan. Bacterial
burden was determined using qPCR and compared to growth in
unstimulated cells. (C) B6 MEFs transfected with empty vector or
an expression vector for human IDO were infected with C.
trachomatis in the presence or absence of tryptophan. Bacterial load
was determined using qPCR. Significant differences between +/-
trp (B) and control vector versus hIDO-expressing cells (C) were
determined by two-tailed students t-test (*, p ,0.05).
Found at: doi:10.1371/journal.ppat.1001346.s001 (0.10 MB TIF)
Figure S2 Nos2 plays a minimal role in eliminating C.
trachomatis in IRG-deficient mice. Wildtype, Irgm1/m3
(-/-)
Nos2
(-/-), Irgm1/m3
(-/-) and GR1-depleted Irgm1/m3
(-/-) mice were
transcervically infected with C. trachomatis and intrauterine
bacterial burden was determined at 15 days post-infection.
Intrauterine bacterial burden between the different mouse strains
was not significantly different (n.s.). In contrast, GR1-depletion
significantly increased bacterial burden in Irgm1/m3
(-/-) mice
(*, p,0.05).
Found at: doi:10.1371/journal.ppat.1001346.s002 (0.59 MB EPS)
Figure S3 The ability of Igrm1/m3
(-/-) mice to rapidly
clear infections compared to Ifngr1
(-/-) mice depends on
the CD4+ and GR1+ cell compartments. Wildtype, Irgm1/
m3
(-/-) and Ifngr1
(-/-) mice were either treated with an isotype
control antibody or with CD4- and GR1-depleting antibodies. At
15 days post-infection, intrauterine bacterial burden was deter-
mined by qPCR. Elevated burden in Ifngr1
(-/-) mice compared to
Irgm1/m3
(-/-) mice was observed in the isotype control group
(*, p,0.1), but not in the CD4/GR1-depleted group.
Found at: doi:10.1371/journal.ppat.1001346.s003 (0.47 MB EPS)
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